Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Recondo

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cancer|August 15, 1990
A phase II study of cisplatin and continuous infusion of vindesine in metastatic head and neck squamous cell cancerE Tellez-Bernal, G Recondo, T Guillot, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase I and pharmacokinetic study of brequinar (DUP 785; NSC 368390) in cancer patientsM de Forni, G G Chabot, J P Armand, et al.
The Laryngoscope|May 1, 1991
Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapyG Recondo, J P Armand, E Tellez-Bernal, et al.
Journal of the National Cancer Institute|April 17, 1991
Computed tomographic density of metastatic lymph nodes as a treatment-related prognostic factor in advanced head and neck cancerJ N Munck, E Cvitkovic, J D Piekarski, et al.
Cancer|November 15, 1991
Neoadjuvant chemotherapy consisting of cisplatin and continuous infusions of bleomycin and 5-fluorouracil for advanced head and neck cancer. The need for a new stratification for stage IV (M0) diseaseG Recondo, E Cvitkovic, N Azli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2020
Clinicopathological and genomic correlates of programmed cell death ligand 1 (PD-L1) expression in nonsquamous non-small-cell lung cancerG Lamberti, L F Spurr, Y Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracilP Wibault, M A Bensmaine, M de Forni, et al.
European Journal of Cancer (Oxford, England : 1990)|May 4, 2001
A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patientsA Zori Comba, C Blajman, E Richardet, et al.
ESMO Open|June 26, 2022
Human papillomavirus infection and lung adenocarcinoma: special benefit is observed in patients treated with immune checkpoint inhibitorsL Rojas, D Mayorga, A Ruiz-Patiño, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cancer|August 15, 1990
A phase II study of cisplatin and continuous infusion of vindesine in metastatic head and neck squamous cell cancerE Tellez-Bernal, G Recondo, T Guillot, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase I and pharmacokinetic study of brequinar (DUP 785; NSC 368390) in cancer patientsM de Forni, G G Chabot, J P Armand, et al.
The Laryngoscope|May 1, 1991
Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapyG Recondo, J P Armand, E Tellez-Bernal, et al.
Journal of the National Cancer Institute|April 17, 1991
Computed tomographic density of metastatic lymph nodes as a treatment-related prognostic factor in advanced head and neck cancerJ N Munck, E Cvitkovic, J D Piekarski, et al.
Cancer|November 15, 1991
Neoadjuvant chemotherapy consisting of cisplatin and continuous infusions of bleomycin and 5-fluorouracil for advanced head and neck cancer. The need for a new stratification for stage IV (M0) diseaseG Recondo, E Cvitkovic, N Azli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2020
Clinicopathological and genomic correlates of programmed cell death ligand 1 (PD-L1) expression in nonsquamous non-small-cell lung cancerG Lamberti, L F Spurr, Y Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracilP Wibault, M A Bensmaine, M de Forni, et al.
European Journal of Cancer (Oxford, England : 1990)|May 4, 2001
A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patientsA Zori Comba, C Blajman, E Richardet, et al.
ESMO Open|June 26, 2022
Human papillomavirus infection and lung adenocarcinoma: special benefit is observed in patients treated with immune checkpoint inhibitorsL Rojas, D Mayorga, A Ruiz-Patiño, et al.
Pageof 2